|
ZNF782 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.293840E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.184600E-03 |
| Normal-vs-Stage2 |
4.136000E-01 |
| Normal-vs-Stage3 |
3.829600E-02 |
| Normal-vs-Stage4 |
4.882100E-02 |
| Stage1-vs-Stage2 |
5.813400E-01 |
| Stage1-vs-Stage3 |
9.955200E-01 |
| Stage1-vs-Stage4 |
8.614600E-01 |
| Stage2-vs-Stage3 |
6.468800E-01 |
| Stage2-vs-Stage4 |
6.268600E-01 |
| Stage3-vs-Stage4 |
8.395200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.443970E-02 |
| Normal-vs-AfricanAmerican |
1.129220E-01 |
| Normal-vs-Asian |
2.137800E-02 |
| Caucasian-vs-AfricanAmerican |
8.074200E-01 |
| Caucasian-vs-Asian |
4.722600E-01 |
| AfricanAmerican-vs-Asian |
4.561200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.258300E-03 |
| Normal-vs-Female |
3.117400E-01 |
| Male-vs-Female |
2.450600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.219600E-03 |
| Normal-vs-Extreme_Weight |
4.375300E-03 |
| Normal-vs-Obese |
2.205000E-01 |
| Normal-vs-Extreme_Obese |
9.453800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.652200E-01 |
| Normal_Weight-vs-Obese |
1.241790E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.866400E-01 |
| Extreme_Weight-vs-Obese |
1.439960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.869400E-01 |
| Obese-vs-Extreme_Obese |
5.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.778400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.420000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.040290E-03 |
| Normal-vs-Age(81-100Yrs) |
2.038000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.375200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.321200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.013200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.462900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.120400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.170000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.675900E-02 |
| Normal-VS-Type2 PRCC |
4.399300E-04 |
| Normal-VS-KIRP CIMP |
1.342050E-01 |
| Normal-VS-Unclassified PRCC |
3.776200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.799800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.495000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.365400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.210400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.621630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.189000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.043100E-04 |
| Normal-vs-N1 |
8.894200E-01 |
| Normal-vs-N2 |
1.990180E-02 |
| N0-vs-N1 |
2.751900E-02 |
| N0-vs-N2 |
5.410400E-01 |
| N1-vs-N2 |
1.710000E-01 |
|
|
